Lewis H. Titterton Jr.

Filings by Lewis H. Titterton Jr. span 2 companies, the busiest being Anixa Biosciences Inc and Parkervision Inc. In total, 113 filings cover trades dated from 8 February 2011 to 23 September 2026.

In open-market terms, that means 89 purchases worth €3.0M on one side and 1 sale worth €578k on the other. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants and 11 option exercises. 2026 to date brings 5 purchases and no sales.

The median purchase comes to €14k. Relative to company size, the median is 0.036% of market cap (4 purchases with a known value). Clusters matter here: 44 out of 47 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 25 September 2026, the filings show an open-market purchase worth €115k in Anixa Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.